Loading chat...
IN HB1171
Bill
Status
1/7/2016
Primary Sponsor
Robert Heaton
Click for details
AI Summary
Summary of SB 161
-
Amends Indiana criminal law and pharmacy regulations concerning the sale and tracking of ephedrine and pseudoephedrine to prevent methamphetamine manufacturing.
-
Requires pharmacies and NPLEx retailers to implement electronic sales tracking through the National Precursor Log Exchange (NPLEx) and establish daily, 30-day, and 365-day purchase limits (3.6, 7.2, and 61.2 grams respectively).
-
Mandates pharmacists make professional determinations regarding legitimate medical need for ephedrine or pseudoephedrine purchases and allows refusal of sales with civil immunity protections.
-
Expands the INSPECT prescription monitoring program to include ephedrine and pseudoephedrine tracking alongside controlled substances, with reporting timelines accelerating from 7 days to 24 hours after dispensing.
-
Establishes procedures for state court administration to notify the NPLEx system of certain felony convictions and allows NPLEx to issue stop sale alerts preventing individuals from purchasing precursor chemicals.
Legislative Description
Disability income insurance. Requires that a policy of disability income insurance must include provisions: (1) allowing for designation of an individual to receive certain notices; and (2) specifying a grace period for premium payment. Specifies that noncompliance does not create liability or a cause of action and may not be used as evidence.
Last Action
First reading: referred to Committee on Insurance
1/7/2016